EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Targeted degradation of BRD4 by PROTACs: advances in cancer therapy

Yanyun Hong, Xiang Liu, Yinglong Li, Mengting Yu, Caolin Wang, Cunpeng Nie, Shan Xu

Chemical Communications · 2026 · 62 (17) · 4869-4888

DOI: 10.1039/d5cc05563f ↗

At a glance

Übersichtsarbeit in Chemical Communications, 2026. Written by Yanyun Hong and 6 co-authors. Institution: Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 33001…. Major MEDLINE topics: Neoplasms, Transcription Factors, Cell Cycle Proteins, Antineoplastic Agents. Cited 5 times so far (Crossref); 145 references. Funded by: Natural Science Foundation of Jiangxi Province, Jiangxi Science and Technology Normal University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

This schematic illustrates the multidimensional optimization strategies for BRD4-targeting PROTACs, encompassing the rational design of the ternary complex, diverse controllable activation systems, and targeted delivery approaches.

Subjects

MeSH terms (MEDLINE)

NeoplasmsTranscription FactorsCell Cycle ProteinsAntineoplastic AgentsHumansBromodomain Containing ProteinsProteolysis Targeting ChimeraProteolysisAnimals

Substances

Bromodomain Containing ProteinsProteolysis Targeting ChimeraBRD4 protein, humanTranscription FactorsCell Cycle ProteinsAntineoplastic Agents

Authors and institutions

  • Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, Jiangxi, China. shanxu9891@126.com.
  • East China University of Science and Technology, Shanghai, China.

Funding

  • Natural Science Foundation of Jiangxi Province
  • Jiangxi Science and Technology Normal University

Cite

APA

Hong, Y., Liu, X., Li, Y., Yu, M., Wang, C., Nie, C., & Xu, S. (2026). Targeted degradation of BRD4 by PROTACs: advances in cancer therapy. Chemical Communications, 62(17), 4869-4888. https://doi.org/10.1039/d5cc05563f

Vancouver

Hong Y, Liu X, Li Y, Yu M, Wang C, Nie C, et al. Targeted degradation of BRD4 by PROTACs: advances in cancer therapy. Chemical Communications. 2026;62(17):4869-4888. doi:10.1039/d5cc05563f

BibTeX
@article{Hong2026,
  author = {Hong, Yanyun and Liu, Xiang and Li, Yinglong and Yu, Mengting and Wang, Caolin and Nie, Cunpeng and Xu, Shan},
  title = {Targeted degradation of BRD4 by PROTACs: advances in cancer therapy},
  journal = {Chemical Communications},
  year = {2026},
  volume = {62},
  number = {17},
  pages = {4869--4888},
  doi = {10.1039/d5cc05563f}
}
Start for free →